Home Orthofix International N.V.

Orthofix International N.V.

Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System

3/22/18: New system adds treatment options for Charcot foot and broadens the Company’s Extremity Fixation portfolio of products

Publication of Data Further Confirms Effectiveness of the Orthofix Cervical-Stim Device in Improving Fusion Rates

3/5/18: Orthofix International N.V., (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products and value-added services, today announced the publication of new data in Bone & Joint Research from a study evaluating the effect of pulsed electromagnetic field treatment for patients who have an increased risk for pseudoarthrosis (failure for the vertebrae to fuse) after anterior cervical discectomy and fusion procedures.

Orthofix Introduces New Brand Identity for Extremity Fixation Pediatric Products

“With a long history of developing innovative and cutting edge extremity fixation technologies, Orthofix has now brought...